edgepedia

Life and health scientists

18,587 articles

Theresa A Kadlecek

Theresa A. Kadlecek is an immunologist and research specialist at the Howard Hughes Medical Institute laboratory at UCSF, known for the 1994 Science paper identifying ZAP-70 deficiency in SCID.

Theresa L. Walunas

Theresa L. Walunas is an American immunologist and biomedical informatician, first author of the 1994 paper showing CTLA-4 is a negative regulator of T cell activation.

Theresa M. Marteau

Theresa M. Marteau, also known as Theresa Marteau, is a British psychologist and behavioral scientist who directs the Behaviour and Health Research Unit at the University of Cambridge.

Thérèse Tréfouël

Thérèse Tréfouël, born Thérèse Boyer, was a French chemist at the Institut Pasteur who in 1935 showed that sulfanilamide, not the dye prontosil, was the active antibacterial agent.

Thi Hoang Duong Nguyen

Thi Hoang Duong (Kelly) Nguyen, born 1987, is a structural biologist at the MRC Laboratory of Molecular Biology known for cryo-EM structures of human telomerase.

Thierry André

Thierry André is a French medical oncologist, professor at Sorbonne Université and head of medical oncology at Hôpital Saint-Antoine, Paris, known for leading the MOSAIC and KEYNOTE-177 colorectal cancer trials.

Thierry Boon

Thierry Boon-Falleur, born in Belgium in 1944, is a Belgian immunologist at UCLouvain known for discovering the MAGE family of human tumor antigens in 1991.

Thierry Calandra

Thierry Calandra, born 1956 in Lausanne, is a Swiss physician-scientist known for showing in 2000 that blocking macrophage migration inhibitory factor protects against septic shock.

Thierry Façon

Thierry Façon (born 1959) is a French hematologist and professor who heads the hematology service at CHU de Lille, known for leading myeloma trials including FIRST, MAIA, and IMROZ.

Thierry H. LeJemtel

Thierry H. LeJemtel is a French-trained cardiologist specializing in advanced heart failure and transplant cardiology, Henderson Chair Professor of Medicine at Tulane University School of Medicine since 2005.

Thierry Philip

Thierry Philip (born 1949) is a French medical oncologist and professor at Université Lyon 1 who directed Centre Léon-Bérard and chaired Institut Curie in Paris from 2013 to 2024.

Thierry Poynard

Thierry Poynard, born in 1950, is a French hepatologist known for hepatitis C clinical research and for inventing FibroTest, a blood-based alternative to liver biopsy.

Thierry Soussi

Thierry Soussi (born 1956) is a French cancer researcher and professor at Sorbonne Université in Paris, known for his work on the TP53 tumor suppressor gene and for building the UMD TP53 mutation database.

Thijs Ettema

Thijs Ettema, also known as Thijs J. G. Ettema, is a Dutch evolutionary microbiologist, chair professor of Microbiology at Wageningen University since 2019, known for discovering the Asgard archaea.

Thilo Stehle

Thilo Stehle is a German structural virologist and biochemist who heads the Biochemistry Institute at the University of Tübingen and determined the structures of polyomaviruses.

Thirumala-Devi Kanneganti

Thirumala-Devi Kanneganti is an immunologist at St. Jude Children's Research Hospital in Memphis who studies innate immunity and inflammasomes, and is known for defining PANoptosis, a lytic inflammatory cell death pathway driven by PANoptosome complexes.

Thomas A. Blanpied

Thomas A. Blanpied is an American neuroscientist at the University of Maryland School of Medicine who studies the nanoscale organization of glutamatergic synapses and received the 2007 PECASE award.

Thomas A. Buchanan

Thomas A. Buchanan is a physician-scientist at the Keck School of Medicine of USC known for research on gestational diabetes and diabetes prevention in Hispanic Americans.

Thomas A. Cooper

Thomas A. Cooper is an American physician-scientist and molecular biologist at Baylor College of Medicine in Houston, known for work on RNA splicing and myotonic dystrophy type 1.

Thomas A. Ferguson

Thomas A. Ferguson is an immunologist at Washington University in St. Louis who studies cell death, immune privilege, and autophagy in the eye, including corneal transplant success.

Thomas A. Gaziano

Thomas A. Gaziano is an American cardiologist and health-decision scientist, associate professor at Harvard Medical School and the Harvard Chan School, who studies cost-effective cardiovascular disease prevention in developing countries.

Thomas A. Kunkel

Thomas A. Kunkel is an American biochemist at NIEHS known for work on DNA replication fidelity, elected to the National Academy of Sciences in 2024.

Thomas A. Pearson

Thomas A. Pearson is an American cardiovascular epidemiologist, professor at the University of Florida since 2013, known for heart disease prevention research and national prevention guidelines.

Thomas A. Reh

Thomas A. Reh is a neuroscientist and Professor of Biological Structure at the University of Washington who studies retinal regeneration, seeking to restore sight by reprogramming Müller glia into neurons.

Thomas A. Spies

Thomas A. Spies is an American immunologist at Fred Hutchinson Cancer Research Center in Seattle, known for discovering the TAP1 antigen-presentation gene and the NKG2D ligands MICA and MICB.

Thomas A. Stamey

Thomas A. Stamey (1928–2015) was an American urological surgeon and founding chair of the Department of Urology at Stanford University, who helped establish the PSA blood test in American practice.

Thomas A. Steitz

Thomas A. Steitz (1940–2018) was an American structural biologist at Yale who determined the 50S ribosomal subunit structure and shared the 2009 Nobel Prize in Chemistry.

Thomas A. Wadden

Thomas A. Wadden is an American clinical psychologist and obesity researcher at the University of Pennsylvania who directed its Center for Weight and Eating Disorders from 1993 to 2017.

Thomas A. Waldmann

Thomas A. Waldmann was an American immunologist who led the National Cancer Institute's Metabolism Branch from 1971 to 2019, developed daclizumab, and described Waldmann disease.

Thomas A. Wynn

Thomas A. Wynn is an American immunologist known for establishing how type 2 immune responses drive fibrosis, after 26 years at the NIH and a 2017 move to Pfizer.